scholarly article | Q13442814 |
P50 | author | Young Jin Jeong | Q56974268 |
P2093 | author name string | Hyun Jin Yoon | |
Young Jin Jeong | |||
Do-Young Kang | |||
P2860 | cites work | Alzheimer's Disease | Q22248111 |
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease | Q24203739 | ||
Mechanisms of Aβ Clearance and Degradation by Glial Cells | Q26741609 | ||
Neuropathological alterations in Alzheimer disease | Q27003314 | ||
Neuroinflammation in Alzheimer's disease | Q28259238 | ||
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory | Q29614724 | ||
Microglia: a sensor for pathological events in the CNS | Q29620556 | ||
Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions. | Q30873038 | ||
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. | Q33697980 | ||
Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging | Q33904501 | ||
Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis | Q34042034 | ||
Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity | Q34100175 | ||
Molecular imaging of microglia/macrophages in the brain | Q34276818 | ||
Neuroinflammation in Alzheimer's disease and prion disease. | Q34963776 | ||
Local neuroinflammation and the progression of Alzheimer's disease | Q35022588 | ||
Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study | Q35935113 | ||
Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia | Q36775208 | ||
Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. | Q37720604 | ||
Inflammation in neurodegenerative diseases | Q37766302 | ||
Is Alzheimer's a disease of the white matter? | Q38089525 | ||
Glucose pathways adaptation supports acquisition of activated microglia phenotype | Q38186639 | ||
Brain PET in suspected dementia: patterns of altered FDG metabolism | Q38211221 | ||
Oligodendrocytes and Alzheimer's disease | Q38497880 | ||
Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases? | Q38677275 | ||
Neuroinflammation in Alzheimer's disease: Current evidence and future directions | Q38834651 | ||
Typical cerebral metabolic patterns in neurodegenerative brain diseases | Q42952840 | ||
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study | Q46373170 | ||
An early and late peak in microglial activation in Alzheimer's disease trajectory | Q48339994 | ||
Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia. | Q48529217 | ||
Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease. | Q52138509 | ||
In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. | Q53416070 | ||
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome | Q70908071 | ||
White matter amyloid in Alzheimer's disease brain | Q71773128 | ||
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
Fluorodeoxyglucose Positron Emission Tomography | Q130273243 | ||
P304 | page(s) | e9042 | |
P577 | publication date | 2017-12-01 | |
P1433 | published in | Medicine | Q15716652 |
P1476 | title | Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET. | |
P478 | volume | 96 |
Q89460111 | Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease |
Q89820448 | Utility of Absolute Quantification in Non-lesional Extratemporal Lobe Epilepsy Using FDG PET/MR Imaging |
Q57290382 | Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease |
Search more.